Phase I Trial of the HSP90 Inhibitor PF-04929113 (SNX5422) in Adult Patients With Recurrent, Refractory Hematologic Malignancies
Author:
Funder
NCRR/NIH
Pfizer Inc
Rachel Mason
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference24 articles.
1. HSP90 and the chaperoning of cancer;Whitesell;Nat Rev Cancer,2005
2. Inhibitors of the heat shock response: biology and pharmacology;Powers;FEBS Lett,2007
3. The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation;Grenert;J Biol Chem,1997
4. Heat shock protein 90;Neckers;Curr Opin Oncol,2003
5. A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas;Cerchietti;Nat Med,2009
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combination therapy involving HSP90 inhibitors for combating cancer: an overview of clinical and preclinical progress;Archives of Pharmacal Research;2024-04-17
2. Cardiotoxicity;Side Effects of Cancer Therapy;2023-12-11
3. Targeting Borrelia burgdorferi HtpG with a berserker molecule, a strategy for anti-microbial development;Cell Chemical Biology;2023-11
4. Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol;Bioorganic & Medicinal Chemistry;2022-12
5. Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance;Cells;2022-09-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3